CD8A and acute myeloid leukemia: Given the substantial influence of CD8+ T cells on both the efficiency of immunotherapy and prognosis in AML, we intend to explore whether a prognostic model built on CD8 T-related genes can accurately forecast the survival rates of AML patients.